Cardiol Therapeutics (CRDL) Liabilities and Shareholders Equity: 2021

Historic Liabilities and Shareholders Equity for Cardiol Therapeutics (CRDL) over the last 1 years, with Dec 2021 value amounting to $70.1 million.